National Lab Briefs

Livermore Decides Not To Blow Its Stack In a decision hailed by environmentalists, Lawrence Livermore National Lab announced it wants to cancel construction of an on-site incinerator whose stack would have emitted small amounts of radioactivity. But Director John Nuckolls' proposal to go ahead with the rest of what is known as a Decontamination and Waste Treatment Facility is likely to embroil the lab in another lengthy round of regulatory agency battles. The incinerator was part of a plan to r

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Livermore Decides Not To Blow Its Stack
In a decision hailed by environmentalists, Lawrence Livermore National Lab announced it wants to cancel construction of an on-site incinerator whose stack would have emitted small amounts of radioactivity. But Director John Nuckolls' proposal to go ahead with the rest of what is known as a Decontamination and Waste Treatment Facility is likely to embroil the lab in another lengthy round of regulatory agency battles. The incinerator was part of a plan to replace the lab's existing waste management operations. Without it, the lab is left without an approved long-term alternative plan for disposal of mixed waste (waste containing toxic and radioactive materials).

A spokesman for the Department of Energy, which must approve the plan, makes clear that "the final decision will be made using an overall DOE waste management strategy." But he says that the department "welcomes the input" of the internal ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies